logo

For the Inventor, By the Inventor

Fishers, IN, United States of America

Julie Kay Bush

This inventor holds 10 USPTO granted patents and 4 EPO patents. Top assignee: Eli Lilly and Company. Active years: 2003-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julie Kay Bush. Retrieved from https://idiyas.com/inventor/julie-kay-bush

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 10.0

 

Average Co-Inventor Count = 2.1

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Fishers, IN (US) (2003 - 2012)
  • McCordsville, IN (US) (2012)

Company Filing History:

goldMedal10 out of 4,517 
 
Eli Lilly and Company
 patents

Years Active: 2003-2012

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 8153807 - Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 (2012-04-10),
2. 8114901 - Crystalline 2,5-dione-3-(1-methyl-1H-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1H-indol-3-yl]-1H-pyrrole mono-hydrochloride (2012-02-14),
3. 7932249 - Olanzapine pamoate dihydrate (2011-04-26),
4. 7834187 - Crystalline variable hydrate of (S)-6-(4-(2-((3-9H-carbazol-4-yloxy)-2-hydroxypropyl)amino)-2-methylpropyl)phenoxy)-3-pyridinecarbox amide hemisuccinate salt (2010-11-16),
5. 7582762 - Salt and crystalline forms of (2R)-anti-5-{3-[4-(10,11-difluoromethanodibenzosuber-5-YL)piperazin-1-YL]-2-hydroxypropoxy}quinoline (2009-09-01),
6. 7282585 - Salt and crystalline forms of (2R)-anti-5-{3-[4-(10,11-difluoromethanodibenzosuber-5-yl)piperazin-1-yl]-2-hydroxypropoxy}quinoline (2007-10-16),
7. 7160922 - Hemihydrate of a selective functional M1 muscarine receptor agonist (2007-01-09),
8. 6653479 - Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b] thiophene hydrochloride (2003-11-25),
9. 6610706 - Crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride (2003-08-26),
10. 6521755 - Process for preparing 10,11-methanobenzosuberane derivatives (2003-02-18),

Title: Julie Kay Bush: Innovator in Pharmaceutical Science

Introduction

Julie Kay Bush is a prominent inventor based in Fishers, IN (US). She has made significant contributions to the field of pharmaceutical science, holding a total of 10 patents. Her work primarily focuses on developing novel compounds that address various health conditions.

Latest Patents

Among her latest patents is an invention titled "Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1." This invention discloses novel compounds of Formula I that exhibit 11-HSD type 1 antagonist activity. The patent also includes methods for preparing these compounds and pharmaceutical compositions that utilize them to treat conditions such as diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, and metabolic syndrome. Another notable patent is for "Crystalline 2,5-dione-3-(1-methyl-1H-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1H-indol-3-yl]-1H-pyrrole mono-hydrochloride." This invention relates to a crystalline salt that is used in pharmaceutical formulations for treating cancer and inhibiting tumor growth.

Career Highlights

Julie Kay Bush is currently employed at Eli Lilly and Company, where she continues to innovate in the pharmaceutical sector. Her work has been instrumental in advancing treatments for various medical conditions, showcasing her expertise and dedication to improving patient outcomes.

Collaborations

Some of her notable coworkers include Susan Marie Reutzel-Edens and Preston Charles Conrad. Their collaborative efforts contribute to the innovative environment at Eli Lilly and Company.

Conclusion

Julie Kay Bush is a remarkable inventor whose work in pharmaceutical science has led to significant advancements in treatment options for various health conditions. Her contributions are vital to the ongoing development of effective therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…